Dr. Phillips is a national leader in the treatment of hematologic malignancies and is an innovator in bringing transplant modalities to lymphoma. He is a graduate of the University of Oklahoma School of Medicine where he completed his internship in internal medicine. He continued his residency training at the University of North Carlina School of Medicine and trained at Washington University School of Medicine with a clinical and research fellowship in hematology/oncology. He previously directed the transplant programs at the University of Maryland, University of Kentucky, theUniversity of British Columbia, and Barnes Hospital at the Washington University School of Medicine. Dr. Phillips was the principal investigator of the National Cancer Institute (NCI) study "Improving the Ability of (High-Risk) Hematologic Malignancy Patients to Undergo Allogenic Stem Cell Transplantation".
Dr. Phillips is a member of several editorial boards and has authored and/or co-authored over 200 publications. His research interests include nonmyeloablative (min-dose) transplants and 'alternative donors' for allogenic transplants. He has developed several innovative clinical trials related to stem cell transplantation and is particularly interested in lymphoma, leukemia, and multiple myeloma.
|Fellowship, American College of Physicians/American Society of Internal Medicine
|Bringing Clinical Renown to Vancouver General Hospital", Vancouver General Hospital Academic Awards Day
|Outstanding Teacher, Washington University School of Medicine
|American Board of Medical Oncology
|American Cancer Society Junior Faculty Award (renewed 1979 and 1980)
|American Board of Internal Medicine
|Outstanding Resident in Medicine, University of North Carolina School of Medicine
|Physiology Award, University of Oklahoma School of Medicine